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See related research by Chen et al., http://ccforum.com/content/18/6/675We would like to comment on the excellent review by
Chen and colleagues highlighting the safety and efficacy of
combining extracorporeal membrane oxygenation (ECMO)
and continuous renal replacement therapy (CRRT) for
fluid and electrolyte control [1].
As a high-flow system equipped with heparin-coated
membranes and circuits, ECMO requires no or only min-
imal additional anticoagulation to assure circuit patency
[2,3]. In contrast, CRRT essentially remains a low-flow
system that demands specific anticoagulation to avoid
early circuit clotting [2,3]. Thus, creating a two-in-one
ECMO/CRRT system will have evident limitations and
drawbacks. The introduction of a hemofiltration filter in-
side the ECMO circuit renders ultrafiltrate volume re-
moval inaccurate and prohibits pressure monitoring in the
circuit, thereby reducing the filter lifespan. Embedding a
full CRRT device in series with an ECMO circuit may
obviate these shortcomings. However, the dramatic dif-
ference in flow and pressure will increase shear stress, ac-
tivate the clotting cascade and release noxious cytokines,
which exposes patients to the potential life-threatening
effects of hemolysis, disseminated intravascular coagula-
tion and enhanced systemic inflammation [4,5]. Moreover,
a hemolysis-induced excessive rise of plasma-free hemo-
globin and subsequent hemoglobinuria adversely affects
renal tubular function and may induce or exacerbate acute
kidney injury [4,5].* Correspondence: Patrick.Honore@uzbrussel.be
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unless otherwise stated.For these reasons, we strongly argue against the com-
bined use of ECMO and CRRT within a single circuit. In
addition, a separate CRRT device can perfectly run under
a proper dedicated anticoagulation therapy (for example,
regional citrate). This permits avoidance of ECMO-induced
anticoagulant dilution, resulting in less thrombotic
events [2].
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